JC
MDT icon

JB Capital’s Medtronic MDT Stock Holding History

JB Capital’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.61M Sell
71,678
-127,010
-64% -$10.2M 0.19% 61
2026
Q1 		$17.2M Buy
198,688
+52,378
+36% +$5.02M 0.7% 33
2025
Q4 		$14.1M Buy
146,310
+8,695
+6% +$845K 0.57% 32
2025
Q3 		$13.1M Buy
137,615
+10,152
+8% +$933K 0.57% 31
2025
Q2 		$11.1M Buy
127,463
+6,515
+5% +$553K 0.54% 33
2025
Q1 		$10.9M Buy
120,948
+4,071
+3% +$364K 0.6% 30
2024
Q4 		$9.34M Buy
116,877
+6,381
+6% +$552K 0.52% 33
2024
Q3 		$9.95M Buy
110,496
+5,083
+5% +$428K 0.57% 30
2024
Q2 		$8.3M Buy
105,413
+5,908
+6% +$484K 0.52% 35
2024
Q1 		$8.67M Buy
99,505
+9,452
+10% +$807K 0.58% 34
2023
Q4 		$7.42M Buy
90,053
+10,177
+13% +$776K 0.55% 35
2023
Q3 		$6.26M Buy
79,876
+14,464
+22% +$1.21M 0.53% 34
2023
Q2 		$5.76M Buy
65,412
+3,259
+5% +$281K 0.49% 35
2023
Q1 		$5.01M Buy
62,153
+1,748
+3% +$142K 0.46% 36
2022
Q4 		$4.69M Buy
60,405
+3,944
+7% +$320K 0.46% 47
2022
Q3 		$4.56M Buy
+56,461
New +$5.07M 0.5% 37

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

JB Capital's MDT Position: Q2 2026 in Review

JB Capital reduced its Medtronic (MDT) stake by 64% in Q2 2026, selling an estimated $10.2M and leaving 71,678 shares worth $5.61M. The position accounts for 0.19% of the portfolio, ranked #61.

JB Capital first reported a position in MDT in Q3 2022 and has held it in 16 quarters since. The position peaked at $17.2M in Q1 2026. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • JB Capital held 71,678 shares of Medtronic worth $5.61M as of Q2 2026.
  • JB Capital sold 127,010 Medtronic shares in Q2 2026, an estimated $10.2M.
  • Medtronic made up 0.19% of JB Capital's portfolio in Q2 2026, its #61 holding.
  • JB Capital first reported a position in Medtronic in Q3 2022 and has held it in 16 quarters since.
  • JB Capital's Medtronic position peaked at $17.2M in Q1 2026.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on JB Capital's 13F filing for Q2 2026, filed 29 Jul 2026.